Healthcare Triangle Secures $15.2 Million in PIPE Offering to Fuel Strategic Growth

Healthcare Triangle, Inc., a digital transformation solutions provider for healthcare and life sciences industries, has completed a significant private investment in public equity (PIPE) offering, raising approximately $15.2 million in gross proceeds. The strategic financial move positions the company to advance its technological capabilities and market expansion initiatives.

The offering, priced according to Nasdaq market rules, consisted of 36,190,485 units, each comprising a share of common stock or pre-funded warrant, along with series A and B warrants. Investors can purchase additional shares at an exercise price of $0.84, providing potential future investment opportunities.

Net proceeds from the offering, totaling approximately $13.68 million after deducting placement agent fees and expenses, will be allocated toward strategic objectives. The company plans to leverage these funds for potential acquisitions, general corporate purposes, and addressing working capital requirements, demonstrating a proactive approach to financial management and growth.

By securing this funding, Healthcare Triangle has reinforced its financial stability, achieving compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The PIPE offering reflects investor confidence in the company's technological expertise and potential for expansion in the rapidly evolving healthcare technology landscape.

RBW Capital Partners LLC and Spartan Capital Securities, LLC served as co-placement agents for the transaction, with legal counsel provided by Sichenzia Ross Ference Carmel LLP and Manatt, Phelps & Phillips, LLP. The strategic financial transaction underscores Healthcare Triangle's commitment to innovative digital transformation solutions in the healthcare and life sciences sectors.